Bakhtyar Ali is the CEO and Founder of Amrixa Pharmaceuticals, a biotechnology company that is pioneering first-in-class mRNA-based therapeutics. Amrixa is developing mRNA-based protein replacement therapies and repurposing biologically unique viruses for self-replicating mRNA platform design. In addition to his role at Amrixa, Bakhtyar is the Co-Founder and COO at OpenLabs, a 501(c)(3) non-profit wet lab network focused on building low entry barrier BSL-1/2 laboratory incubators with high operational biosecurity standards.